Results 51 to 60 of about 1,568 (118)

[Pharmacological prescription: inhalers and antimicrobials]. [PDF]

Aten Primaria
Barrio Díez I, Rodríguez Ferré AM.
europepmc   +1 more source

[Chronic Pain and the Redistribution of Epistemic Power: From Technological Reductionism to Clinical Generalism]. [PDF]

Aten Primaria
Novoa Jurado AJ.
europepmc   +1 more source

[Use of prescription drugs in Spain and Europe]. [PDF]

Aten Primaria, 2012
Simó Miñana J.
europepmc   +1 more source

[FASEa-C Project: Pharmacists Joining the Team in Chronic Care Monitoring]. [PDF]

Aten Primaria
Méndez Esteban MI, Araujo Bueno ML, Gasca Salas D, Soriano Fuentes S, Tineo Justicia S, González Monedero F.   +5 more
europepmc   +1 more source

Dipyrone use in Brazil: clinical conditions, sociodemographic characteristics, population attitudes and perceptions. [PDF]

Cad Saude Publica
Medeiros EFF, Tavares NUL, Barros DSL, Pizzol TDSD, Fontanella AT, Mendonça-Silva DL, Mengue SS, Neves FAR.   +7 more
europepmc   +1 more source

[Patient-centered clinical ultrasound: Reflections prompted by a recent article]. [PDF]

Aten Primaria
Carbajo Martín L, Párraga-Martínez I, Beltrán Romero LM, Bernabeu Wittel M, Grupo de Investigación AGS Norte de Huelva. Hospital de Riotinto.   +4 more
europepmc   +1 more source

[Telegeriatrics for chronic disease management through polypharmacy reduction in primary health careTelegeriatria para o controle de doenças crônicas por meio da redução da polifarmácia na atenção primária à saúde]. [PDF]

Rev Panam Salud Publica
Ponce S, Galimany J, Fasce G, Arancibia S.   +3 more
europepmc   +1 more source

[Antidepressants in Primary Care]. [PDF]

Aten Primaria
Vázquez Canales LM.
europepmc   +1 more source

[Cost-utility study of a high-resolution consultation (CARE-A) for the treatment of asthma exacerbations]. [PDF]

Open Respir Arch
Medina Gallardo JF, Maestre Sánchez MV, Muñoz Sánchez B, Ferrer Galván M, Romero Falcón A, León Lloreda A, Álvarez Gutiérrez FJ.   +6 more
europepmc   +1 more source

[Initial clinical experience with ribociclib in advanced HR+/HER2- breast cancer in Uruguay]. [PDF]

Rev Med Inst Mex Seguro Soc
Camejo-Martínez N, Strazzarino-Peluffo N, Amarillo-Hernández C D, Castillo-Leska C, Krygier-Waltier G.   +4 more
europepmc   +1 more source